Cepheid's Xpert CT/NG assay for the detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae, launched in the US at the start of the year, has seen the greatest uptake of any new Xpert test since Xpert MRSA, President and CEO John Bishop
NEW YORK (GenomeWeb News) – A research team using whole-genome sequencing to track a form of methicillin-resistant Staphylococcus aureus found in livestock and humans has uncovered genetic evidence confirming animal-to-human transmission of the bug during at least one farm outbreak in De
Carpegen, a German company providing real-time PCR-based testing services to dental practices, this week unveiled a beta version of its benchtop, cartridge-based, sample-to-answer molecular diagnostics platform.
Finnish molecular diagnostics firm Abacus Diagnostica, fresh off winning a pair of key US patents covering its DNA testing technologies, plans to seek regulatory approval in the US next year for tests to detect Staphylococcus aureus and methicillin-resistant S.
NEW YORK (GenomeWeb News) – Becton Dickinson segment BD Diagnostics said today its BD Max MRSA molecular test has received a Moderate Complexity rating under the Clinical Laboratory Improvement Amendments of 1988.
NEW YORK (GenomeWeb News) – A Leerink Swann survey of diagnostic laboratories in Europe found that molecular-based testing continues to find traction with continued penetration strongest in methicillin-resistant Staphylococcus aureus testing and human papillomavirus testing.